These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31019414)

  • 1. Labelling and Clinical Performance of Human Leukocytes Labelled with
    Auletta S; Riolo D; Varani M; Lauri C; Galli F; Signore A
    Contrast Media Mol Imaging; 2019; 2019():4368342. PubMed ID: 31019414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and testing of a new disposable sterile device for labelling white blood cells.
    Signore A; Glaudemans AW; Malviya G; Lazzeri E; Prandini N; Viglietti AL; De Vries EF; Dierckx RA
    Q J Nucl Med Mol Imaging; 2012 Aug; 56(4):400-8. PubMed ID: 23013669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Succinylated gelatine: an alternative to hydroxyethyl starch for labelling leukocytes with 99mTc-HMPAO.
    Roca M; Armero F; Jiménez I; Rodríguez-Gasén A; Díaz C; Martín-Comín J
    Nucl Med Commun; 2005 Aug; 26(8):749-52. PubMed ID: 16000996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro study to compare 99mTc-stannous colloids and 99mTc-HMPAO for labelling human leukocytes.
    Capriotti G; D'Alessandria C; Garin E; Weber E; Devillers A; Lehmann K; Corsetti F; Lecloirec J; Meller J; Becker W; Moisan A; Signore A
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):229-36. PubMed ID: 15499297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Cell Fraction of
    Kim EM; Jeong HJ; Lim ST; Sohn MH
    Curr Radiopharm; 2020; 13(2):142-148. PubMed ID: 32386504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGB1 expression in leukocytes as a biomarker of cellular damage induced by [
    Follacchio GA; Manganelli V; Monteleone F; Sorice M; Garofalo T; Liberatore M
    Nucl Med Biol; 2021; 96-97():94-100. PubMed ID: 33864964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Media Fill Test for validation of autologous leukocytes separation and labelling by (99m)Tc-HmPAO.
    Urbano N; Modoni S; Schillaci O
    Nucl Med Biol; 2013 Jan; 40(1):104-8. PubMed ID: 23078874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of Binding Kinetics and Specificity of
    Auletta S; Iodice V; Galli F; Lepareur N; Devillers A; Signore A
    Contrast Media Mol Imaging; 2018; 2018():5603902. PubMed ID: 30498401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiolabeled WBC scintigraphy in the diagnostic workup of patients with suspected device-related infections.
    Erba PA; Sollini M; Conti U; Bandera F; Tascini C; De Tommasi SM; Zucchelli G; Doria R; Menichetti F; Bongiorni MG; Lazzeri E; Mariani G
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1075-1086. PubMed ID: 24011775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-in-human infection imaging with
    Kahts M; Summers B; Ndlela AN; Gutta A; Nemutaduni P; More A; Parsoo A; Ebenhan T; Zeevaart JR; Aras O; Sathekge MM
    Front Nucl Med; 2024; 4():1426650. PubMed ID: 39355210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of Tc-99m D,L-HMPAO preparations as a leucocyte labelling agent.
    Kao CH; Huang WT; Tsai CS
    Appl Radiat Isot; 1998 Dec; 49(12):1595-8. PubMed ID: 9745694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-besilesomab (Scintimun) in peripheral osteomyelitis: comparison with 99mTc-labelled white blood cells.
    Richter WS; Ivancevic V; Meller J; Lang O; Le Guludec D; Szilvazi I; Amthauer H; Chossat F; Dahmane A; Schwenke C; Signore A
    Eur J Nucl Med Mol Imaging; 2011 May; 38(5):899-910. PubMed ID: 21321791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraindividual comparison of 99mTc-labelled anti-SSEA-1 antigranulocyte antibody and 99mTc-HMPAO labelled white blood cells for the imaging of infection.
    Gratz S; Behr T; Herrmann A; Dresing K; Tarditi L; Franceschini R; Rhodes B; Stürmer KM; Becker W
    Eur J Nucl Med; 1998 Apr; 25(4):386-93. PubMed ID: 9553168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labelling of leukocytes with 99mTc-HMPAO for scintigraphy of inflammatory lesions and abscesses.
    Vanlić-Razumenić N; Pujić N; Dedović N; Kostić K; Nastić-Mirić D
    Int J Rad Appl Instrum B; 1992 Apr; 19(3):251-6. PubMed ID: 1629013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of 99Tcm-HMPAO and 99Tcm-ECD as a leukocyte labelling agent.
    Kao CH; Huang WT; Wang YL; Lin KS; Lo JM; Wang SJ
    Nucl Med Commun; 1994 Apr; 15(4):294-7. PubMed ID: 8072744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
    Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stabilization of 99m Tc-HMPAO with methylene blue: its use in leukocyte labelling)].
    García Seguí V; Roca Engroñat M; Armero Muñoz F; Iglesias Allende F; Gomes Barreto de Mélo V; Martin-Comín J
    Rev Esp Med Nucl; 1998; 17(4):261-4. PubMed ID: 9721341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of 99Tcm-d,l-HMPAO and 99Tcm-d,l-CBPAO as leukocyte-labelling agents.
    Tsai CS; Kao CH; Yeh SJ; Wang SJ
    Nucl Med Commun; 1996 Jan; 17(1):76-9. PubMed ID: 8692477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tc-99m HMPAO labelled WBCs in the detection of occult sepsis in the intensive care unit.
    Kao CH; Wang YL; Liao SQ; Wang SJ
    Intensive Care Med; 1992; 18(1):15-9. PubMed ID: 1578041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99mTc-HMPAO-labeled WBC scan for the diagnosis of chronic recurrent multifocal osteomyelitis.
    Dailey TA; Berven MD; Vroman PJ
    J Nucl Med Technol; 2014 Dec; 42(4):299-301. PubMed ID: 25168250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.